학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 50건 | 목록
1~20
Academic Journal
Hamilton, Erika P; Ma, Cynthia; De Laurentiis, Michelino; Iwata, Hiroji; Hurvitz, Sara A; Wander, Seth A; Danso, Michael; Lu, Dongrui R; Perkins Smith, Julia; Liu, Yuan; Tran, Lana; Anderson, Sibyl; Campone, Mario
Future Oncology; 2024, Vol. 20 Issue 32, p2447-2455, 9p
Academic Journal
Knutson KL; Department of Immunology, Mayo Clinic, Jacksonville, Florida.; Department of Cancer Biology, Mayo Clinic, Jacksonville, Florida.; Abu-Fares H; Department of Immunology, Mayo Clinic, Jacksonville, Florida.; Keating P; Department of Biological Sciences, Florida Atlantic University, Boca Raton, Florida.; Block MS; Department of Oncology, Mayo Clinic, Rochester, Minnesota.; Department of Immunology, Mayo Clinic, Rochester, Minnesota.; Norton N; Department of Cancer Biology, Mayo Clinic, Jacksonville, Florida.; Erskine CL; Department of Immunology, Mayo Clinic, Rochester, Minnesota.; Cogen D; Department of Immunology, Mayo Clinic, Jacksonville, Florida.; Assad H; Karmanos Cancer Institute, Detroit, Michigan.; Graff SL; Research Medical Center, Kansas City, Missouri.; Hamilton EP; Sarah Cannon Research Institute, Nashville, Tennessee.; Han HS; Moffitt Cancer Center, Tampa, Florida.; McIntyre KJ; Texas Oncology, Dallas, Texas.; Nassar A; Department of Pathology and Laboratory Medicine, Mayo Clinic, Jacksonville, Florida.; Sparano JA; Montefiore Medical Center, Bronx, New York.; Tiersten A; Mount Sinai Hospital, New York, New York.; Tkaczuk KH; University of Maryland, Baltimore, Maryland.; Ward PJ; Oncology Hematology Care, Cincinnati, Ohio.; Wilson G; TapImmune, Jacksonville, Florida.; Garrett G; TapImmune, Jacksonville, Florida.; Marker Therapeutics, Houston, Texas.; Kenney RT; TapImmune, Jacksonville, Florida.; Marker Therapeutics, Houston, Texas.; Sharma P; University of Kansas Cancer Center, Westwood, Kansas.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Lloyd MR; Beth Israel Deaconess Medical Center, Boston, Massachusetts.; Weipert CM; Guardant Health, Inc., Redwood City, California.; Ali A; Cleveland Clinic Foundation, Taussig Cancer Institute, Cleveland, Ohio.; Solomon SR; Guardant Health, Inc., Redwood City, California.; Saha J; Guardant Health, Inc., Redwood City, California.; Lipsyc-Sharf MD; UCLA Health Jonsson Comprehensive Cancer Center, Los Angeles, California.; Hamilton EP; Sarah Cannon Research Institute, Nashville, Tennessee.; Kalinsky K; Winship Cancer Institute at Emory University, Atlanta, Georgia.; Brufsky AM; University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.; Bardia A; UCLA Health Jonsson Comprehensive Cancer Center, Los Angeles, California.; Zhang N; Guardant Health, Inc., Redwood City, California.; Wander SA; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Patel MR; Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, Florida, USA.; Hamilton EP; Sarah Cannon Research Institute, Nashville, Tennesse, USA.; George B; Medical College of Wisconsin, Milwaukee, Wisconsin, USA.; Kretschmar G; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.; Harada A; Nippon Boehringer Ingelheim Co., Ltd., Kobe, Japan.; Graeser R; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.; Astra Zeneca, Barcelona, Spain.; Eleftheraki A; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.; Tachibana Y; Nippon Boehringer Ingelheim Co., Ltd., Tokyo, Japan.; Yamamoto N; National Cancer Center Hospital, Tokyo, Japan.
Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE
Academic Journal
Patel MR; Florida Cancer Specialists, 600 N Cattlemen Rd, Suite #200, Sarasota, FL, 34232, USA. mpatel@flcancer.com.; Sarah Cannon Research Institute, Nashville, TN, USA. mpatel@flcancer.com.; Falchook GS; Sarah Cannon Research Institute at HealthONE, Denver, CO, USA.; Wang JS; Florida Cancer Specialists, 600 N Cattlemen Rd, Suite #200, Sarasota, FL, 34232, USA.; Sarah Cannon Research Institute, Nashville, TN, USA.; Imedio ER; Oncology R&D, AstraZeneca, Cambridge, UK.; Kumar S; Oncology R&D, AstraZeneca, Cambridge, UK.; Miah K; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Boston, MA, USA.; Mugundu GM; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Boston, MA, USA.; Jones SF; Sarah Cannon Research Institute, Nashville, TN, USA.; Spigel DR; Sarah Cannon Research Institute, Nashville, TN, USA.; Hamilton EP; Sarah Cannon Research Institute, Nashville, TN, USA.
Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE
Academic Journal
Goetz, Matthew P; Hamilton, Erika P; Campone, Mario; Hurvitz, Sara A; Cortes, Javier; Johnston, Stephen; Llombart-Cussac, Antonio; Kaufman, Peter A; Toi, Masakazu; Jerusalem, Guy; Graham, Hillary; Wang, Hong; Jansen, Valerie M; Litchfield, Lacey M; Martín, Miguel
Clin Cancer Res
CLINICAL CANCER RESEARCH
r-FISABIO. Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
CLINICAL CANCER RESEARCH
r-FISABIO. Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Academic Journal
Hamilton EP; Sarah Cannon Research Institute, 250 25th Avenue North, Nashville, TN, 37203, USA. Erika.Hamilton@scri.com.; Falchook GS; Sarah Cannon Research Institute at HealthONE, Denver, CO, USA.; Wang JS; Sarah Cannon Research Institute, 250 25th Avenue North, Nashville, TN, 37203, USA.; Florida Cancer Specialists, Sarasota, FL, USA.; Fu S; MD Anderson Cancer Center, Houston, TX, USA.; Oza AM; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada.; Imedio ER; Oncology R&D, AstraZeneca, Cambridge, UK.; Kumar S; Oncology R&D, AstraZeneca, Cambridge, UK.; Ottesen L; Oncology R&D, AstraZeneca, Cambridge, UK.; Mugundu GM; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Boston, MA, USA.; de Bruin EC; Oncology R&D, AstraZeneca, Cambridge, UK.; O'Connor MJ; Oncology R&D, AstraZeneca, Cambridge, UK.; Jones SF; Sarah Cannon Research Institute, 250 25th Avenue North, Nashville, TN, 37203, USA.; Spigel DR; Sarah Cannon Research Institute, 250 25th Avenue North, Nashville, TN, 37203, USA.; Li BT; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE
Academic Journal
Campone M; Institut de Cancérologie de l'Ouest Angers-Nantes, Saint-Herblain, France.; De Laurentiis M; Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale,' Naples, Italy.; Jhaveri K; Memorial Sloan Kettering Cancer Center, New York.; Weill Cornell Medical College, New York.; Hu X; Shanghai Cancer Center, Fudan University, Shanghai, China.; Ladoire S; Centre Georges Francois Leclerc, Dijon, France.; Patsouris A; Institut de Cancérologie de l'Ouest Angers-Nantes, Angers, France.; Zamagni C; IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy.; Cui J; First Hospital of Jilin University, Changchun, China.; Cazzaniga M; Phase 1 Research Unit, Fondazione IRCCS San Gerardo, Monza, Italy.; Cil T; Health and Science University, Adana City Hospital, Adana, Turkey.; Jerzak KJ; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto.; Fuentes C; Fundación Respirar, Buenos Aires.; Yoshinami T; Graduate School of Medicine, Osaka University, Osaka, Japan.; Rodriguez-Lescure A; Hospital General Universitario de Elche, Elche, Spain.; Sezer A; Baskent University Adana Application and Research Center, Adana, Turkey.; Fontana A; Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.; Guarneri V; Veneto Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy.; University of Padova, Padua, Italy.; Molckovsky A; Grand River Regional Cancer Centre, Kitchener, ON, Canada.; Mouret-Reynier MA; Centre Jean Perrin, Clermont-Ferrand, France.; Demirci U; Memorial Ankara Hospital, Ankara, Turkey.; Zhang Y; Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing.; Valota O; Pfizer, Milan.; Lu DR; Pfizer, San Diego, CA.; Martignoni M; Pfizer, Milan.; Parameswaran J; Arvinas Operations, New Haven, CT.; Zhi X; Arvinas Operations, New Haven, CT.; Hamilton EP; Breast Cancer Research Program, Sarah Cannon Research Institute, Nashville.
Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE
Academic Journal
Rugo HS; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. Electronic address: HRugo@COH.org.; Bardia A; UCLA Health Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA.; Gradishar WJ; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.; Hamilton EP; Sarah Cannon Research Institute, Nashville, TN, USA.; Hurvitz SA; University of Washington Fred Hutchinson Cancer Center, Seattle, WA, USA.; Jhaveri K; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Mahtani R; Miami Cancer Institute, Baptist Health South Florida, Miami, FL, USA.; Tolaney SM; Dana-Farber Cancer Institute, Boston, MA, USA.
Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE
Academic Journal
Hamilton EP; Sarah Cannon Research Institute, 335 24th Ave North Ste 300, Nashville, TN, 37203, USA. erika.hamilton@scri.com.; Patel MR; Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, FL, USA.; Borges VF; Anschutz Medical Campus, University of Colorado Cancer Center, Aurora, CO, USA.; Meisel JL; Winship Cancer Institute, Emory University, Atlanta, GA, USA.; Okera M; Cancer Research SA, Adelaide, SA, Australia.; Alemany CA; AdventHealth Cancer Institute, Orlando, FL, USA.; Pluard TJ; Saint Luke's Cancer Institute - Koontz Center for Advanced Breast Cancer, Kansas City, MO, USA.; Wesolowski R; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.; Sabanathan D; Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia.; Miller KD; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN, USA.; Conlin AK; Providence Cancer Institute, Portland, OR, USA.; McCarthy N; ICON Cancer Centre, Auchenflower, QLD, Australia.; Shaw M; Olema Oncology, San Francisco, CA, USA.; Tonda M; Olema Oncology, San Francisco, CA, USA.; Shilkrut M; Olema Oncology, San Francisco, CA, USA.; Lin NU; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE
Academic Journal
Hamilton, Erika R.; Kaklamani, Virginia; Falkson, Carla; Vidal, Gregory A.; Ward, Patrick J.; Patre, Monika; Chui, Stephen Y.; Rotmensch, Jacob; Gupta, Kushagra; Molinero, Luciana; Yijin Li; Emens, Leisha A.; Hamilton, Erika P; Li, Yijin
Clinical Breast Cancer; Dec2021, Vol. 21 Issue 6, p539-551, 13p
Academic Journal
Hamilton EP; Breast Cancer Research Program, Sarah Cannon Research Institute, 335 24th Avenue North, Suite 300, Nashville, TN, 37203, USA. erika.hamilton@scri.com.; Jeselsohn RM; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Vahdat LT; Hematology/Oncology, Dartmouth Cancer Center, Lebanon, NH, USA.; Department of Medicine, Geisel School of Medicine, Dartmouth College, Hanover, NH, USA.; Hurvitz SA; Division of Hematology Oncology, Department of Medicine, UW Medicine, Seattle, WA, USA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE
Academic Journal
Hamilton EP; Medical Oncology, Sarah Cannon Research Institute, Nashville, TN, USA.; Loibl S; Forschungs GmbH, German Breast Group, Neu-Isenburg, Germany.; Bachelot T; Medical Oncology Department, Centre Léon Bérard, Lyon, France.; Gnant M; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Niikura N; Department of Breast Surgery, Tokai University, Tokyo, Japan.; Park YH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Seoul, South Korea.; Tolaney SM; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Pistilli B; Department of Medical Oncology, Gustave Roussy Cancer Center, Villejuif, France.; Rastogi P; Department of Hematology and Oncology, Department of Medicine, University of Pittsburgh and NSABP Foundation, Pittsburgh, PA, USA.; Saini KS; Medical Oncology, Fortrea, Inc, Durham, NC, USA.; Gioni I; Late Development Oncology R&D, AstraZeneca, Cambridge, UK.; Johnston S; Late Development Oncology R&D, AstraZeneca, Cambridge, UK.; Nunes R; Late Development Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.; Quintana A; Late Development Oncology R&D, AstraZeneca, Cambridge, UK.; Stuart M; Late Development Oncology R&D, AstraZeneca, Cambridge, UK.; Syta E; Late Development Oncology R&D, AstraZeneca, Toronto, Canada.; Walding A; Late Development Oncology R&D, AstraZeneca, Cambridge, UK.; Klinowska T; Late Development Oncology R&D, AstraZeneca, Cambridge, UK.; Mayer IA; Late Development Oncology R&D, AstraZeneca, Gaithersburg, NJ, USA.
Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE
Academic Journal
Okines AFC; The Royal Marsden NHS Foundation Trust, London, UK.; Curigliano G; Istituto Europeo di Oncologia, IRCCS, Milan, Italy.; University of Milano, Milan, Italy.; Mizuno N; Aichi Cancer Center Hospital, Nagoya, Japan.; Oh DY; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, South Korea.; Rorive A; CHU Sart Tilman Liège, University of Liège, Liège, Belgium.; Soliman H; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Takahashi S; Cancer Institute Hospital of JFCR, Tokyo, Japan.; Bekaii-Saab T; Mayo Clinic, Scottsdale, AZ, USA.; Burkard ME; UW Carbone Cancer Center, University of Wisconsin, Madison, WI, USA.; Chung KY; Prisma Health Institute, Greenville, SC, USA.; Debruyne PR; Kortrijk Cancer Centre, General Hospital AZ Groeninge, Kortrijk, Belgium.; Medical Technology Research Centre (MTRC), School of Life Sciences, Anglia Ruskin University, Cambridge, UK.; School of Nursing and Midwifery, University of Plymouth, Plymouth, UK.; Fox JR; Rocky Mountain Cancer Center, Boulder, CO, USA.; Gambardella V; Hospital Clínico Universitario de Valencia, Valencia, Spain.; Gil-Martin M; Institut Català d'Oncologia L'Hospitalet-IDIBELL, Hospitalet de Llobregat, Spain.; Hamilton EP; Sarah Cannon Research Institute, Nashville, TN, USA.; Monk BJ; Florida Cancer Specialists and Research Institute, West Palm Beach, FL, USA.; Nakamura Y; National Cancer Center Hospital East, Kashiwa, Japan.; Nguyen D; City of Hope National Medical Center, Duarte, CA, USA.; O'Malley DM; The Ohio State University and James Comprehensive Cancer Center, Columbus, OH, USA.; Olawaiye AB; University of Pittsburgh Medical Center, Pittsburgh, PA, USA.; Pothuri B; Laura & Isaac Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.; Reck M; Department of Thoracic Oncology, Airway Research Center North, Germany Center for Lung Disease, Grosshansdorf, Germany.; Sudo K; National Cancer Center, Tokyo, Japan.; Sunakawa Y; St. Marianna University Hospital, Kawasaki, Japan.; Van Marcke C; Cliniques Universitaires Saint-Luc, Brussels, Belgium.; Yu EY; Fred Hutchinson Cancer Center/University of Washington, Seattle, WA, USA.; Ramos J; Pfizer, Bothell, WA, USA.; Tan S; Pfizer, Bothell, WA, USA.; Bieda M; Pfizer, Bothell, WA, USA.; Stinchcombe TE; Duke Cancer Institute, Durham, NC, USA.; Pohlmann PR; University of Texas MD Anderson Cancer Center, Houston, TX, USA. prpohlmann@mdanderson.org.
Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE
Academic Journal
Dasari A; MD Anderson Cancer Center, Houston, TX, USA. ADasari@mdanderson.org.; Hamilton EP; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN, USA.; Falchook GS; Sarah Cannon Research Institute at HealthONE, Denver, CO, USA.; Wang JS; Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, FL, USA.; Li D; City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA, USA.; Sung MW; Tisch Institute at The Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Chien C; HUTCHMED International Corporation, Florham Park, NJ, USA.; Nanda S; HUTCHMED International Corporation, Florham Park, NJ, USA.; Tucci C; HUTCHMED International Corporation, Florham Park, NJ, USA.; Hahka-Kemppinen M; HUTCHMED International Corporation, Florham Park, NJ, USA.; Paulson AS; Baylor Sammons Cancer Center, Dallas, TX, USA.
Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE
Academic Journal
Jhaveri KL; Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY.; Lim E; Garvan Institute of Medical Research, St Vincent's Clinical School, University of New South Wales, Darlinghurst, NSW, Australia.; Jeselsohn R; Dana-Farber Cancer Institute, Boston, MA.; Ma CX; Washington University School of Medicine, St Louis, MO.; Hamilton EP; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN.; Osborne C; US Oncology Research, McKesson Specialty Health, The Woodlands, TX.; Texas Oncology, Baylor-Sammons Cancer Center, Dallas, TX.; Bhave M; Emory University, Atlanta, GA.; Kaufman PA; University of Vermont Cancer Center, Burlington, VT.; Beck JT; Highlands Oncology Group, Springdale, AR.; Manso Sanchez L; Hospital Universitario 12 de Octubre, Madrid, Spain.; Parajuli R; University of California, Irvine, CA.; Wang HC; China Medical University Hospital, Taichung, Taiwan.; Tao JJ; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD.; Im SA; Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.; Harnden K; Inova Schar Cancer Institute, Fairfax, VA.; Yonemori K; National Cancer Center Hospital, Tokyo, Japan.; Dhakal A; University of Rochester Medical Center, Rochester, NY.; Neven P; Universitaire Ziekenhuizen-Leuven Cancer Institute, Leuven, Belgium.; Aftimos P; Université Libre de Bruxelles, Hôpital Universitaire de Bruxelles, Institut Jules Bordet, Brussels, Belgium.; Pierga JY; Institut Curie, Université Paris Cité, Paris, France.; Lu YS; National Taiwan University Hospital, Taipei, Taiwan.; Larson T; Minnesota Oncology/The US Oncology Network, Minneapolis, MN.; Jerez Y; Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, Madrid, Spain.; Sideras K; Mayo Clinic, Jacksonville, FL.; Sohn J; Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.; Kim SB; University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.; Saura C; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Bardia A; Massachusetts General Hospital, Boston, MA.; Sammons SL; Dana-Farber Cancer Institute, Boston, MA.; Duke Cancer Institute, Duke University, Durham, NC.; Bacchion F; Eli Lilly and Company, Indianapolis, IN.; Li Y; Eli Lilly and Company, Indianapolis, IN.; Yuen E; Eli Lilly and Company, Indianapolis, IN.; Estrem ST; Eli Lilly and Company, Indianapolis, IN.; Rodrik-Outmezguine V; Eli Lilly and Company, Indianapolis, IN.; Nguyen B; Eli Lilly and Company, Indianapolis, IN.; Ismail-Khan R; Eli Lilly and Company, Indianapolis, IN.; Smyth L; Eli Lilly and Company, Indianapolis, IN.; Beeram M; START Center for Cancer Care, San Antonio, TX.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Hamilton EP; Sarah Cannon Research Institute, Nashville, Tennessee.
Publisher: Millennium Medical Pub Country of Publication: United States NLM ID: 101167661 Publication Model: Print Cited Medium: Internet ISSN: 1543-0790 (Print) Linking ISSN: 15430790 NLM ISO Abbreviation: Clin Adv Hematol Oncol Subsets: MEDLINE
Hamilton EP; Sarah Cannon Research Institute at Tennessee Oncology, Nashville, Tennessee.
Publisher: Millennium Medical Pub Country of Publication: United States NLM ID: 101167661 Publication Model: Print Cited Medium: Internet ISSN: 1543-0790 (Print) Linking ISSN: 15430790 NLM ISO Abbreviation: Clin Adv Hematol Oncol Subsets: MEDLINE
Academic Journal
Bardia A; Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Krop IE; Yale Cancer Center, New Haven, CT.; Dana-Farber Cancer Institute, Boston, MA.; Kogawa T; Department of Advanced Medical Development, Cancer Institute Hospital of JFCR, Tokyo, Japan.; Juric D; Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Tolcher AW; South Texas Accelerated Research Therapeutics, San Antonio, TX.; NEXT Oncology, San Antonio, TX.; Texas Oncology, San Antonio, TX.; Hamilton EP; Sarah Cannon Research Institute, Nashville, TN.; Tennessee Oncology, PLLC, Nashville, TN.; Mukohara T; Department of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.; Lisberg A; Department of Medicine, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA.; Shimizu T; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.; Department of Pulmonary Medicine and Medical Oncology, Wakayama Medical University Hospital, Wakayama, Japan.; Spira AI; Virginia Cancer Specialists (VCS) Research Institute, Fairfax, VA.; Tsurutani J; Advanced Cancer Translational Research Institute, Showa University, Tokyo, Japan.; Damodaran S; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.; Papadopoulos KP; Clinical Research, START, San Antonio, TX.; Greenberg J; Global Oncology Clinical Development, Daiichi Sankyo, Inc, Basking Ridge, NJ.; Global Oncology Clinical Development, Daiichi Sankyo Europe GmbH, Munich, Germany.; Kobayashi F; Data Intelligence, Daiichi Sankyo, Co, Ltd, Tokyo, Japan.; Zebger-Gong H; Global Oncology Clinical Development, Daiichi Sankyo Europe GmbH, Munich, Germany.; Wong R; Global Oncology Clinical Development, Daiichi Sankyo, Co, Ltd, Tokyo, Japan.; Kawasaki Y; Global Oncology Clinical Development, Daiichi Sankyo, Inc, Basking Ridge, NJ.; Nakamura T; Data Intelligence, Daiichi Sankyo, Co, Ltd, Tokyo, Japan.; Meric-Bernstam F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Rastogi P; UPMC Hillman Cancer Center and NSABP Foundation, Pittsburgh, PA.; O'Shaughnessy J; Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, TX.; Martin M; Hospital General Universitario Gregorio Marañon, Universidad Complutense, CIBERONC, GEICAM, Madrid, Spain.; Boyle F; Sydney Medical School, University of Sydney, Sydney, Australia.; Cortes J; International Breast Cancer Center (IBCC), Quironsalud Group, Barcelona, Spain.; Rugo HS; USCF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA.; Goetz MP; Mayo Clinic, Rochester, MN.; Hamilton EP; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN.; Huang CS; National Taiwan University Hospital, Taipei, Taiwan.; Senkus E; Medical University of Gdańsk, Gdańsk, Poland.; Tryakin A; N.N. Blokhin Russian Cancer Research Center, Moscow, Russian Federation.; Cicin I; Istinye University, Istanbul, Turkey.; Testa L; D'Or Institute for Research and Education (IDOR), São Paulo, Brazil.; Neven P; University Hospitals Leuven, Louvain, Belgium.; Huober J; Kantonsspital St Gallen, St Gallen, Switzerland.; Shao Z; Fudan University Shanghai Cancer Center, Shanghai, China.; Wei R; Eli Lilly and Company, Indianapolis, IN.; André V; Eli Lilly and Company, Indianapolis, IN.; Munoz M; Eli Lilly and Company, Indianapolis, IN.; San Antonio B; Eli Lilly and Company, Indianapolis, IN.; Shahir A; Eli Lilly and Company, Indianapolis, IN.; Harbeck N; Comprehensive Cancer Centre München, LMU University Hospital, Munich, Germany.; Johnston S; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Hamilton, Erika P
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어